HBIO
Harvard Bioscience Inc.

1,581
Loading...
Loading...
News
all
press releases
Harvard Bioscience Sets Incentive Plan for Top Executives
Harvard Bioscience (HBIO) has provided an announcement. Harvard Bioscience, Inc.'s Compensation Committee has recently greenlit the 2024 annual cas...
TipRanks Financial Blog·2y ago
News Placeholder
More News
News Placeholder
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference
HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at...
Globe Newswire·2y ago
News Placeholder
Harvard Bioscience (HBIO, $4.4) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 8, 2024
This is a Bullish indicator signaling HBIO's price could rise from here. Traders may explore going long the stock or buying call options...
Tickeron - Technical Analysis·2y ago
News Placeholder
Q4 2023 Harvard Bioscience Inc Earnings Call Transcript
Related Stocks: NAS:HBIO...
GuruFocus·2y ago
News Placeholder
Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript
Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript...
SeekingAlpha·2y ago
News Placeholder
Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation
Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation...
SeekingAlpha·2y ago
News Placeholder
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
Q4 Revenues of $28.2 millionQ4 Gross Margin of 58.0% (230 bps year-over-year improvement)Q4 operating income of $0.3 million, adjusted operating income of $3.3 millionStrong operating cash flow...
Globe Newswire·2y ago
News Placeholder
Panorama des b n fices de Harvard Bioscience
Harvard Bioscience (NASDAQ:HBIO) est cens e publier ses derniers b n fices ce jeudi. Voici l'opinion de Benzinga\ sur le rapport de r sultats quatri me trimestre de Harvard Bioscience. R sultat net...
Benzinga·2y ago
News Placeholder
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analyticsHOLLISTON, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience...
Globe Newswire·2y ago
News Placeholder
Harvard Bioscience (HBIO, $4.89) price moved above its 50-day Moving Average on February 15, 2024
This price move could indicate a change in the trend, and may be a buy signal for investors...
Tickeron - Stocks·2y ago

Latest HBIO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.